Program By Day

7:00 AM-8:00 AM Complimentary Continental Breakfast
7:00 AM-6:30 PM Exhibits Open
7:50 AM-9:30 AM Welcome and General Session 1: Response Assessment and Individualization of Management of Esophageal Adenocarcinoma (ARS)

TBD - Chair

TBD - Chair


TBD
Welcome of the Day

TBD
Case Presentation

Kenneth Wang, MD
Mayo Clinic
Initial Staging and Response Assessment

TBD
Debate: Management of Esophageal Adenocarcinoma After Neoadjuvant Therapy With Complete Clinical Response—Surgery Versus Watchful Waiting

TBD
Surgeon Perspective

Florence Huguet, MD, PhD
Hopital Tenon
Radiation Oncologist Perspective

David H. Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center
Improving Esophageal Adenocarcinoma Outcomes: Future Directions

Panel Question and Answer
9:30 AM-10:00 AM Break
10:00 AM-11:30 AM General Session 2: Global Outlook on Gastric Cancer

Ulysses Ribeiro Jr., MD, PhD - Chair
University of Sao Paulo

Khaldoun Almhanna, MD - Chair
Moffitt Cancer Center

TBD
Global Perspectives on Surveillance, Risk Factors, and Management of Early Gastric Cancer

TBD
European Perspective

Paola Catherine Montenegro, MD
Instituto Nacional De Enfermedades Neoplasicas
South American Perspective

Seiichiro Abe, MD
National Cancer Center, Tokyo
Asian Perspective

TBD
Foregut Microbiome: Advances in Our Understanding of Its Role in Gastric Cancer and Its Management


Hold for Potential Abstract

Panel Question and Answer
11:30 AM-1:00 PM Poster Session A: Cancers of the Esophagus and Stomach
With Complimentary Boxed Lunch
11:30 AM-1:00 PM Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach
With Complimentary Boxed Lunch
12:00 PM-1:00 PM Trainee and Early-Career Networking Luncheon
1:00 PM-2:00 PM Rapid Fire Abstract Session: Cancers of the Esophagus and Stomach
1:00 PM-2:00 PM Breakout Session: Multidisciplinary Management of Less Common Gastroesophageal Tumors

TBD
Guidelines for Perioperative Imatinib Therapy for Gastrointestinal Stromal Tumors

Field F. Willingham, MD, MPH
Emory University School of Medicine
Evaluation of Gastroesophageal Submucosal Lesions and Minimally Invasive Management Options

Panel Question and Answer
1:00 PM-2:00 PM Breakout Session: FLOT or Not—Perioperative Management for Gastric Cancer

TBD
Pro

Jaffer A. Ajani, MD
The University of Texas MD Anderson Cancer Center
Con

Panel Question and Answer
2:00 PM-2:15 PM Break
2:15 PM-3:45 PM Oral Abstract Session A: Cancers of the Esophagus and Stomach
3:45 PM-4:15 PM Break
4:15 PM-5:30 PM General Session 3: Is There A Role for Locoregional Therapies in Stage IV Esopahgeal and Gastric Cancers? (ARS)

Paola Catherine Montenegro, MD - Chair
Instituto Nacional De Enfermedades Neoplasicas

Manisha Palta, MD - Chair
Duke University Medical Center

TBD
Case Presentation and Discussion

Brian D. Badgwell, MD
University of Texas MD Anderson Cancer Center
Surgical Oncologist Perspective

Elena Elimova, MD
Princess Margaret Cancer Centre
Medical Oncologist Perspective

Maria A Hawkins, MD, MRCP, FRCR
University of Oxford
Radiation Oncologist Perspective
5:30 PM-6:30 PM Complimentary Wine and Cheese Reception
5:45 PM-6:30 PM Poster Walks